ReachRxResearch
Home
Research
Sign Up
A systematic review and narrative synthesis of functional neuroimaging studies for chronic ocular surface pain
Back to Research Hub
  1. Home
  2. Research Hub
  3. A systematic review and narrative synthe…

A systematic review and narrative synthesis of functional neuroimaging studies for chronic ocular surface pain

Survey of Ophthalmology·August 12Open Access
OphthalmologyLimited evidenceChronic Ocular Surface PainPhotophobiaSystematic ReviewBotulinum ToxinFunctional Magnetic Resonance ImagingAdultBotulinum Toxin

Summary

View source

What was studied

A systematic review synthesizing functional neuroimaging studies in adults with chronic ocular surface pain (COSP) or photophobia, covering study designs, methodologies, and cumulative findings across an initial pool of 643 unique studies.

Key findings

Only 5 eligible studies were identified (n=107 total: 83 cases, 24 controls); all used fMRI exclusively. Light consistently activated trigeminocortical nociceptive networks (spinal trigeminal/brainstem, S1, insula, anterior midcingulate), with partial attenuation following topical anesthesia, botulinum toxin, or FL-41 tinted lenses.

Study limitations

- Very small evidence base (5 studies, 107 participants) limits generalizability. - All studies used fMRI only; no other functional neuroimaging modalities (e.g., EEG, MEG) were represented, leaving neural oscillations and neuromodulatory targets unexplored. - Sex imbalance in cases vs. controls (37.3% vs. 29.2% female) and narrow study design homogeneity restrict diversity and broader applicability.

Clinical implications

Clinicians should be aware that COSP and photophobia have measurable central (brain-level) signatures, suggesting brain-based biomarkers may complement surface metrics in assessment and treatment planning. Interventions like topical anesthesia, botulinum toxin, and FL-41 lenses show partial central pain attenuation, but the evidence base remains very limited.

Caveats

  • FL-41 tinted lenses are discussed as an intervention, but no brand tag was assigned as no proprietary name was specified in the paper.
  • Only 5 primary studies met inclusion criteria, making pooled conclusions preliminary at best.
  • The level of evidence is assigned as 2 (systematic review), but the underlying studies are small and methodologically homogeneous, which may overstate confidence in findings.

Related Questions

Explore related topics

What brain regions are activated in chronic ocular surface pain and photophobia on fMRI?How does botulinum toxin affect central pain processing in ocular surface pain?What neuromodulatory treatments are being investigated for chronic ocular surface pain?

Publication Details

Year
2026
Journal
Survey of Ophthalmology
Sample Size
n=107
Source
View article
Keep scrolling
More content below.
Up Next